Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedMV
Modi Ventures
Activity from announced rounds
Activity in this selectionHealthtech
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $103.8M 2 disclosed · full round size, not this investor’s share